Leopan, John L.
HRN: 22-00-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/01/2022
10/08/2022
IV
600mg
Q6
Infected Wound; CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes